Symbotic Tops Q4 Revenue Views, Guides Above Consensus as Shares Jump After Hours

The company signaled continued revenue momentum with a Q1 outlook above Wall Street expectations.

Overview

Symbotic posted Q4 revenue of $618 million, topping the $604.37 million estimate and rising 9.5% year over year.
The company guided Q1 fiscal 2026 revenue to $610–$630 million, with the midpoint above the $606.8 million consensus, and forecast adjusted EBITDA of $49–$53 million.
GAAP results showed a Q4 net loss of $19.1 million, or -$0.03 per share, versus prior-year profit and below the $0.05 EPS expected by analysts.
Cash and equivalents climbed to $1.25 billion at quarter-end, up $467 million sequentially and reinforcing liquidity for deployments.
Shares rose about 7% after hours as investors weighed 26% full-year revenue growth to $2.25 billion, positive adjusted EBITDA, and expansion into healthcare via Medline.